Grace Therapeutics, Inc. (GRCE) — Net Asset Quality Index
Grace Therapeutics, Inc. (GRCE) has a Net Asset Quality Index of 94.7% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $68.49 Million minus total liabilities of $3.60 Million yields net assets of $64.89 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read GRCE current and long-term liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Grace Therapeutics, Inc. Net Asset Quality Index Over Time (2010–2025)
This chart shows how Grace Therapeutics, Inc.'s Net Asset Quality Index has evolved across 15 annual periods from 2010 to 2025. As of December 2025, the index stands at 94.7%, representing net assets of $64.89 Million against total assets of $68.49 Million USD. For live market cap and overall valuation, see market value of Grace Therapeutics, Inc..
Annual Net Asset Quality Index for Grace Therapeutics, Inc. (2010–2025)
The table below presents the year-by-year Net Asset Quality Index for Grace Therapeutics, Inc. from 2010 to 2025, covering 15 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See Grace Therapeutics, Inc. (GRCE) net assets for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 92.5% | $66.61 Million | $71.99 Million | $5.38 Million | ▲ +8.3 pp |
| 2024 | 84.2% | $61.74 Million | $73.30 Million | $11.56 Million | ▼ -1.7 pp |
| 2023 | 85.9% | $67.95 Million | $79.12 Million | $11.17 Million | ▲ +1.7 pp |
| 2022 | 84.2% | $108.27 Million | $128.62 Million | $20.35 Million | ▼ -4.9 pp |
| 2021 | 89.1% | $55.66 Million | $62.46 Million | $6.80 Million | ▲ +32.3 pp |
| 2020 | 56.9% | $12.99 Million | $22.85 Million | $9.86 Million | ▲ +26.9 pp |
| 2019 | 29.9% | $11.04 Million | $36.90 Million | $25.85 Million | ▼ -5.9 pp |
| 2018 | 35.8% | $6.37 Million | $17.78 Million | $11.41 Million | ▼ -59.6 pp |
| 2016 | 95.5% | $20.09 Million | $21.04 Million | $957.12K | ▲ +6.1 pp |
| 2015 | 89.3% | $26.56 Million | $29.74 Million | $3.18 Million | ▲ +16.4 pp |
| 2014 | 72.9% | $29.91 Million | $41.01 Million | $11.10 Million | ▼ -7.0 pp |
| 2013 | 79.9% | $9.50 Million | $11.89 Million | $2.39 Million | ▼ -12.1 pp |
| 2012 | 92.0% | $14.55 Million | $15.82 Million | $1.27 Million | ▲ +39.3 pp |
| 2011 | 52.7% | $5.83 Million | $11.07 Million | $5.24 Million | ▲ +7.5 pp |
| 2010 | 45.1% | $4.02 Million | $8.90 Million | $4.88 Million | — |